1. Home
  2. ILMN vs FCNCA Comparison

ILMN vs FCNCA Comparison

Compare ILMN & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • FCNCA
  • Stock Information
  • Founded
  • ILMN 1998
  • FCNCA 1898
  • Country
  • ILMN United States
  • FCNCA United States
  • Employees
  • ILMN N/A
  • FCNCA N/A
  • Industry
  • ILMN Medical Specialities
  • FCNCA Major Banks
  • Sector
  • ILMN Health Care
  • FCNCA Finance
  • Exchange
  • ILMN Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • ILMN 22.9B
  • FCNCA 27.2B
  • IPO Year
  • ILMN 2000
  • FCNCA N/A
  • Fundamental
  • Price
  • ILMN $140.60
  • FCNCA $2,209.89
  • Analyst Decision
  • ILMN Buy
  • FCNCA Buy
  • Analyst Count
  • ILMN 20
  • FCNCA 9
  • Target Price
  • ILMN $160.68
  • FCNCA $2,128.63
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • FCNCA 98.6K
  • Earning Date
  • ILMN 11-04-2024
  • FCNCA 01-24-2025
  • Dividend Yield
  • ILMN N/A
  • FCNCA 0.35%
  • EPS Growth
  • ILMN N/A
  • FCNCA N/A
  • EPS
  • ILMN N/A
  • FCNCA 174.55
  • Revenue
  • ILMN $4,390,000,000.00
  • FCNCA $9,364,000,000.00
  • Revenue This Year
  • ILMN N/A
  • FCNCA N/A
  • Revenue Next Year
  • ILMN $4.28
  • FCNCA N/A
  • P/E Ratio
  • ILMN N/A
  • FCNCA $12.66
  • Revenue Growth
  • ILMN N/A
  • FCNCA 44.77
  • 52 Week Low
  • ILMN $97.36
  • FCNCA $1,363.97
  • 52 Week High
  • ILMN $156.66
  • FCNCA $2,388.78
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 47.51
  • FCNCA 53.22
  • Support Level
  • ILMN $140.56
  • FCNCA $2,162.98
  • Resistance Level
  • ILMN $145.37
  • FCNCA $2,329.02
  • Average True Range (ATR)
  • ILMN 4.75
  • FCNCA 56.37
  • MACD
  • ILMN 0.11
  • FCNCA -9.10
  • Stochastic Oscillator
  • ILMN 60.26
  • FCNCA 28.60

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Share on Social Networks: